Expression of 2-nd Receptor of Tumor Necrosis Factor Cytokine (TNFR-II) in Canine Mammary Neoplasms
Abstract
Actual study proposes an actual and controversial theme in oncology, such as expression and distribution of TNF cytokine 2-nd receptor in canine mammary cancer, and its involvement in cancer progression and prognosis. TNFR-II was evaluated by LSAB immunohistochemistry technique using anti-TNFR-II marker. Tumor malignancy was appreciated using histology grading (I to III), mitotic index, nuclear grade, tumor size, and histology type. In the study were elected benign and malign canine mammary tumors. Distribution and localization of TNFR-II was restricted in both inflammatory cells from the sustaining stroma of studied tumors (macrophage, lymphocyte), and in cancerous epithelial or myoepithelial cells. Obtained dates demonstrate a direct relation between histologic grade and TNFR-II expression; TNFR-II had a lower expression in benign and differentiated grade I canine mammary tumors (cancerous epithelial and myoepithelial cells), and a higher expression in poorly differentiated ones (grade II cancers).
a) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).